Introduction: Common ivy (Hedera helix) is a plant used successfully in the treatment of various ailments. This is possible owing to the unique set of substances contained in it such as large amount of saponins, flavonoids, phenolic acids and phytosterols as well as polyacetylenes and coumarins. All these substances have been used in the production of cosmetic and medicinal preparations. Clinical trials on the efficacy and safety of dry ivy leaf extract have shown its high efficacy, comparable to synthetic medications, and better tolerance of herbal drugs.
Objective: Investigations were performed on model ivy leaf (Hedera helix) extracts which were created using a medium of diversified polarity ( εM). Measurements of viscosity and surface activity on phase boundary were performed. During preformulation studies attention was drawn to the possibility of micellar solubilization of cholesterol and selected structures of nonsteroidal anti-inflammatory drugs (NSAIDs) – ketoprofen.
Methods: Viscosity measurements of Extractum Hederae helicis e folium aqueous solutions and in 0.1 mol HCl were performed according to the Polish Standard with Ubbelohde dilution viscometer. The surface tension of aqueous solutions of Hederae helicis e folium extracts was determined according to the Polish Standard with stalagmometric method. Critical micellar concentration (cmc) was calculated. This enabled to evaluate the dependence RT×log cmc of the thermodynamic potential of micelle formation ( ). Results: It has been confirmed in the conducted comparative studies that aqueous solutions of Extr. Hederae helicis e folium created with maltodextrin as well as with SiO2 – maltodextrin result in micellar solubilization. The increase of granulometric size of cholesterol particle to Ø 1.60 mm decreased the amount of solubilized cholesterol but solubility preferences of the extracts were maintained.
Conclusions: Model extracts produced from Hederae helicis e folium with diversified polarity of the extraction medium (water – ethanol) are characterized by appropriate solubility of the components which results not only from the presence of chlorophyll and its derivatives in the extract but also from the technique used for spray drying of the extract.
1. Nowak E, Nachajski MJ, Zgoda MM. Maidenhair tree (Ginkgo bilobae) leaf extraction product in the light of Biopharmaceutics Classification System (BCS) requirements and medium of diversi-fied polarity ( εM). Herba Pol 2014; 60(1):18-28. doi: http://dx.doi.org/10.2478/hepo-2014-0002
2. Van Wyk BE, Wink M. Medical plants of the world. Pretoria 2005; 167-386.
3. European Medicines Agency, Science Medicines Health, Community Herbal Monograph on Hedera helix L., folium. 31 March 2011, EMA/HMPC/289430/2009 Committee on Herbal Medicinal Products (HMPC).
4. Lutsenko Y, Bylka W, Matławska I, Darmohray R. Hedera helix as a medical plant. Herba Pol 2010; 56(1):84-96.
5. Trute A, Gross J, Mutschler E, Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix. Planta Med 1997; 63 (2):125-129. doi: http://dx.doi.org/10.1055/S-2006-957627
6. Baysal Ӧ, Zeller W. Extract of Hedera helix induces resistance on apple rootstock M26 similar to Acibenzolar – S-metyl against fire blight (Erwinia amylovora). Physiol Molecular Plant P 2004; 65(6):305-315.
7. Equale T, Tilahun G, Debella A, Feleke A, Makonnen E. Haemonchus contortus: In vitro and in vivo anthelmintic activity of aqueous and hydroalkoholic extracts of Hedera helix. Experiment Parasitol 2007; 116:340-345. doi: http://dx.doi.org/10.1016/j.exppara2007.01.019
8. Sareedenchai V, Zidoru Ch. Sequestion of polyacetylenes by the parasite Oroban chehederae (Orobanchaceae) from its host Hedera helix (Araliaceae). Biochem Syst Ecol 2008; 36(10):772-776. doi: http://dx.doi.org/10.1016/j.bse.2008.09.002
9. Gepdiremen A, Mshvildadze V, Sűleyman H, Elias R. Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema. Phytomedicine 2005; 12: 440-444. doi: http://dx.doi.org/10.1016/j.phymed2004.04.005
10. Suleyman H, Mshvildadze V, Gepdiremen A, Elias R. Acute and chronic anti-inflammatory profile of the ivy plant Hedera helix, in rats. Phytomedicine 2003; 10:370-374. doi: http://dx.doi.org/10.1078/0944-7113-00260
11. QuetinLeclercq J, Elias R, Balansard G, Bassleer R, Angenot L. Cytotoxic activity of some triterpe-noid saponins. Planta Med 1992; 59(3): 279-281. doi: http://dx.doi.org/10.1055/S-2006-961456
12. Jeong HG, Park HJ. The prevention of carbon tertrachloride – induced hepatotoxicity in mice by alphahederin inhibition of cytochrome P450 2E1 expression. Biochem Mol Biol Int 1998; 45(1):163-170.
13. Hofmann D, Hecker M, Volp A. Efficacy of dry extract of ivy leaves in children with bronchial asthma – a review of randomized controlled trials. Phytomedicine 2003; 10:213-220. doi: http://dx.doi.org/10.1078/094471103321659979
17. Bedir E, Kirmizipekmez H, Sticher, Callis J. Triterpene saponins from the fruits of Hedera helix. Phytochemistry 2000; 53:905-909.
18. Mendel M, Chłopecka M, Dziekan N, Wiechetek M. The effect of the whole extract of common ivy (Hedera helix) leaves an selected active substances on the motoric activity of rat isolated stomach strips. J Ethnopharmacol 2011; 134:796-802. doi: http://dx.doi.org/10.1016/j.jep.2011.01.036
20. Nachajski MJ, Kołodziejczyk MK, Lukosek M, Kosno J, Kołodziejska J, Zgoda MM. Usefuless of Resens postulate for studying the relationship between the structure of cholic acid oxyethylation products and the process of solubilization of lipophlic therapeutic agents (BCS Class II and III) in aqueous solutions in equilibrium. Acta Pol Pharm 2014; 71(4):637-645.
21. Polska norma – PN-53/C-89430. Tworzywa sztuczne. Zasady normalizacji metod oznaczania liczby lepkościowej and granicznej liczby lepkościowej polimerów w roztworach rozcieńczonych. Dz. Norm and Miar, 3/1993, poz. 5.
22. Makarewicz E, Mikulski T. Właściwości elektrokinetyczne wodnych kopolimerów akrylanowych. Polimery 1998; 43(4):247-251.
23. Polska Norma PN-93/C-98430 (erg. ISO 304 and 6889). Środki powierzchniowo czynne. Oznaczenie napięcia powierzchniowego (γs) i napięcia międzyfazowego (γi). Dz. Norm i Miar, 2/1991, 4.
24. Zgoda MM, Nachajski MJ, Kołodziejczyk MK, Woskowicz MH, Lukosek M. Solubilizing properties of new surface-active agents, products of selective oxyethylation of cholic acid. Part I. PolimMed 2007; 37(4): 21-38.
25. Zgoda MM, Lukosek M, Nachajski MJ.Equilibrium solubilization of lipophilic therapeutic agents by aqueous solutions of products of catalytic oxyethylation of Croda –type lanolin as model excipients of the class of non-ionic surface active agents. Polim Med 2007; 36(1):33-50.
26. Fedors RF. A method for estimating both the solubility parameters and molar volumes of liquids. Polym Eng Sci 1974; 14(2):147-154.